Hybrid approach for harmony transcatheter pulmonary valve replacement

The Harmony (TM) Transcatheter Pulmonary Valve (Medtronic) was recently approved by the Food and Drug Administration for transcatheter pulmonary valve replacement in native right ventricular outflow tracts. Despite this milestone, some patients have main pulmonary arteries that are severely dilated and continue to require surgical pulmonary valve replacement. The hybrid approach combines surgical creation of a landing zone, transcatheter valve deployment, and suture stabilization of the implanted valve. In this case series, we report the first use of a hybrid approach for Harmony (TM) transcatheter pulmonary valve replacement. Two cases are reported with varying approaches for surgical creation of a landing zone followed by successful placement of a Harmony (TM) valve.

Automated summary

This article introduces the recent approval of Medtronic's Harmony™ Transcatheter Pulmonary Valve for transcatheter pulmonary valve replacement in native right ventricular outflow tracts by the Food and Drug Administration. Despite this milestone, some patients with severely dilated main pulmonary arteries still require surgical pulmonary valve replacement. The article reports the first use of a hybrid approach for Harmony™ transcatheter pulmonary valve replacement in two cases with successful valve placement.